Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Cancer Biotherapy & Radiopharmaceuticals|December 13, 2012
Comparison of 211At-PRIT and 211At-RIT of ovarian microtumors in a nude mouse modelSofia H L Frost, Tom Bäck, Nicolas Chouin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 14, 2013
Ex vivo activity quantification in micrometastases at the cellular scale using the α-camera techniqueNicolas Chouin, Sture Lindegren, Sofia H L Frost, et al.
Acta Oncologica (Stockholm, Sweden)|July 27, 2007
Irradiation of myxoid/round cell liposarcoma induces volume reduction and lipoma-like morphologyKatarina Engström, Peter Bergh, Claes-Göran Cederlund, et al.
International Journal of Radiation Oncology, Biology, Physics|September 18, 2007
Therapeutic efficacy of astatine-211-labeled trastuzumab on radioresistant SKOV-3 tumors in nude miceStig Palm, Tom Bäck, Ingela Claesson, et al.
Acta Oncologica (Stockholm, Sweden)|March 8, 2011
The peptide AF-16 decreases high interstitial fluid pressure in solid tumorsMohamed Al-Olama, Annacarin Wallgren, Bengt Andersson, et al.
Nuclear Medicine and Biology|November 28, 2006
Fractionated radioimmunotherapy of intraperitoneally growing ovarian cancer in nude mice with 211At-MX35 F(ab')2: therapeutic efficacy and myelotoxicityJörgen Elgqvist, Håkan Andersson, Tom Bäck, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 14, 2012
Evaluation of effects on the peritoneum after intraperitoneal α-radioimmunotherapy with (211)AtElin Cederkrantz, Eva Angenete, Tom Bäck, et al.
EJNMMI Research|April 26, 2017
Therapeutic efficacy of α-radioimmunotherapy with different activity levels of the 213Bi-labeled monoclonal antibody MX35 in an ovarian cancer modelAnna Gustafsson-Lutz, Tom Bäck, Emma Aneheim, et al.
Cancer|August 23, 2008
Liposarcoma: outcome based on the Scandinavian Sarcoma Group registerKatarina Engström, Peter Bergh, Pelle Gustafson, et al.
Nuclear Medicine and Biology|October 1, 2011
Comparison of therapeutic efficacy and biodistribution of 213Bi- and 211At-labeled monoclonal antibody MX35 in an ovarian cancer modelAnna M E Gustafsson, Tom Bäck, Jörgen Elgqvist, et al.
Pageof 5